España

TEST FOR IMMUNOLOGICAL DETECTION OF THE HUMAN PAPILLOMAVIRUS (HPV)

Features:

  • Differentiation between latent and productive infection of infection by HPV.
  • High prognostic value (> 80%).
  • Possibility of introducing it into cervix cancer prevention programs.
  • Easy procedure, no additional equipment required.

Manufacturer: Viroactiv & Virofem Diagnostik

MSDS

Safety sheets of the reagent.

READ MORE »